Skip to main content
OpenTrials

Clinical trial condition

Mononegavirales Infections

Explore clinical trials studying Mononegavirales Infections. Study availability and eligibility vary by location and protocol.

541 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

Mononegavirales Infections trial results

Completed

Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions

NCT01466062

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
Locations
  • Site Reference ID/Investigator# 56847 Hyōgo, Japan
  • Site Reference ID/Investigator# 56845 Shimotsuke, Japan
  • Site Reference ID/Investigator# 56842 Tokyo, Japan
  • Site Reference ID/Investigator# 56844 Tokyo, Japan
View Trial Details
Completed

Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy Toddlers

NCT00626327

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Chickenpox, +26 more
Locations
  • Site 85 - Birmingham Pediatric Associates, 806 St. Vincent's Drive Birmingham, Alabama, United States
  • Site 86 - Southeastern Pediatrics Associate, 364 Honeysuckle Road Dothan, Alabama, United States
  • Site 00 - Veritas Research LLC/ Stabler Clinic, 300 North College Street, Greenville, Alabama, United States
  • Site 42 - Drug Research and Analysis Corporation, 1758 Parkplace, Suite 200 Montgomery, Alabama, United States
View all 90 locations
View Trial Details
Completed

Study of Motavizumab (MEDI-524) and Palivizumab Administered Sequentially in the Same Respiratory Syncytial Virus (RSV) Season

NCT00316264

Conditions
Chronic Lung Disease and <= 24 Months of Age or, Female Urogenital Diseases and Pregnancy Complications, Infections, +12 more
Locations
  • Department of Paediatrics and Child Health, The Canberra Hospital Garran, Australian Capital Territory, Australia
  • Neonatalogy John Hunter Hospital New Lambton Heights, New South Wales, Australia
  • Caboolture Clinical Research Caboolture, Queensland, Australia
  • University of Queensland, Royal Children's Hospital Herston, Queensland, Australia
View all 19 locations
View Trial Details
Completed

Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection

NCT01107535

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
Locations
  • Site Reference ID/Investigator# 27834 Arequipa, Peru
  • Site Reference ID/Investigator# 6059 Callao, Peru
  • Site Reference ID/Investigator# 27836 Lima, Peru
  • Site Reference ID/Investigator# 27835 Lima, Peru
View Trial Details

Related conditions